Egalet signs on as official sponsor for National Lacrosse League
Participating in this sponsorship deal:
About Sponsor:
Egalet Corporation is a specialty pharmaceutical company that focuses on the commercialization and development of abuse resistant formulations of opioids and other pain care drugs. It was founded as a private company in 1995 in Værløse, Denmark, and now operates as a publicly traded American company headquartered in Wayne, Pennsylvania, a suburb west of the city of Philadelphia.
About Property:
The National Lacrosse League (NLL) is a men's professional indoor lacrosse league in North America. It currently has nine teams—four in Canada and five in the United States.
The National Lacrosse League (NLL), the largest men’s professional indoor lacrosse league in North America, and Egalet Corporation (Nasdaq: EGLT), a specialty pharmaceutical company focused on developing innovative treatments for pain and other conditions, today announced a partnership focused on physician education around responsible pain management. The two-year agreement will include a product symposium at the 2017 NLL Medical Summit to educate physicians on how to help treat pain with a nonsteroidal anti-inflammatory drug (NSAID), which is also a non-narcotic pain management option. Egalet’s product SPRIX® (ketorolac tromethamine) Nasal Spray, is an NSAID approved in the United States for the short term (up to 5 days) management of moderate to moderately severe pain in adults that requires analgesia at the opioid level.
Read more at www.nll.com »
Comparable Deals
Nearby Deals